Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
Neuro-infectious disease
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
Answer from: at Academic Institution
Copaxone.
Sign In
or
Register
to read more
25438
Related Questions
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
What biomarkers best predict the response to B-cell depleting therapies in MS?
How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?
How do you balance the risk of unnecessary treatment with acyclovir against the risk of delaying treatment in encephalitis cases where CSF pleocytosis is absent?
When do you consider repeating CSF studies in a patient with suspected viral encephalitis but overall initially unrevealing CSF?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?